April 14, 2026 04:31 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'ECI deviated from Bihar procedure': Supreme Court raises concerns over voter deletion in Bengal SIR | Noida workers’ protest turns violent: Stones pelted, vehicles damaged over wage hike demand | Oil prices jump above $103 a barrel as US moves to block Iran-linked shipping | I don’t care if they come back or not, says Trump after Iran talks collapse | Legendary singer Asha Bhosle suffers cardiac arrest, hospitalised | Big boost to India–Mauritius ties: S. Jaishankar hands over 90 e-buses | Middle East tension: Iranian delegation arrives in Islamabad for major talks, 10,000 security personnel deployed | Ranveer Singh visits RSS HQ amid Dhurandhar 2 success, triggers speculation | ED raids ex-Bengal minister Partha Chatterjee; SSC scam resurfaces ahead of polls | Amit Shah promises UCC, ₹3,000 aid per month for women and youth in BJP’s Bengal manifesto
Canada
Image credit: Wikimedia Commons

Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant

| @indiablooms | Sep 03, 2022, at 05:03 am

Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.

This vaccine has been approved for use in adults and will become the first COVID-19 vaccine available in Canada that targets Omicron in addition to the original strain of the coronavirus.

Health Canada said in a decision summary made public Thursday, that the new vaccine shows “significantly higher responses” to the Omicron BA.1 virus in comparison to Moderna’s original coronavirus vaccine, officially branded as Spikevax.

Although the updated vaccine was developed to target the Omicron BA.1 variant, clinical trials, says Health Canada suggest the new vaccine still shows a stronger immune response against the more recent mutations of Omicron — BA.4 and BA.5 — which are now dominant.

According to recommendations of the National Advisory Committee on Immunization (NACI) the updated vaccine should be offered to adults who are recommended to receive a fall booster dose.

NACI says that the vaccine could also be offered to adolescents between 12 and 17 with “moderately to severely immunocompromising conditions” and those who have elevated social risk factors.

(Reporting by Asha Bajaj)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.